Ojemda Interactions
There are 389 drugs known to interact with Ojemda (tovorafenib). Of the total drug interactions, 118 are major, 260 are moderate, and 11 are minor.
Medications known to interact with Ojemda
Note: Showing generic names only.
A
- abciximab
- abemaciclib
- abiraterone
- acalabrutinib
- ado-trastuzumab emtansine
- albendazole
- alfentanil
- alpelisib
- alprazolam
- alteplase
- aminolevulinic acid
- aminolevulinic acid topical
- amiodarone
- amlodipine
- amprenavir
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- apremilast
- aprepitant
- ardeparin
- argatroban
- aripiprazole
- armodafinil
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- aspirin
- astemizole
- atazanavir
- atogepant
- atorvastatin
- avacopan
- avanafil
- avapritinib
- axitinib
B
- bedaquiline
- belumosudil
- bepridil
- betrixaban
- bexarotene
- binimetinib
- bivalirudin
- black cohosh
- boceprevir
- bortezomib
- bosutinib
- brentuximab
- brexpiprazole
- brigatinib
- bromfenac
- bromocriptine
- budesonide
- buprenorphine
- buspirone
- butorphanol
C
- cabazitaxel
- cabozantinib
- calaspargase pegol
- cangrelor
- cannabidiol
- caplacizumab
- capmatinib
- carbamazepine
- cariprazine
- cefiderocol
- ceritinib
- cevimeline
- chlorotrianisene
- cilostazol
- citalopram
- clofarabine
- clomipramine
- clopidogrel
- cobicistat
- cobimetinib
- conjugated estrogens
- crizotinib
D
- dabigatran
- daclizumab
- dalteparin
- danaparoid
- daridorexant
- darifenacin
- darolutamide
- darunavir
- dasatinib
- deferasirox
- defibrotide
- delavirdine
- deoxycholic acid
- desirudin
- desvenlafaxine
- dexfenfluramine
- dextran 1
- dextran, high molecular weight
- dextran, low molecular weight
- diclofenac
- dicumarol
- dienestrol topical
- diflunisal
- dihydroergotamine
- diltiazem
- dipyridamole
- docetaxel
- donepezil
- doravirine
- doxorubicin
- doxorubicin liposomal
- dronedarone
- drospirenone
- drotrecogin alfa
- duloxetine
- duvelisib
E
- edoxaban
- efavirenz
- elacestrant
- elagolix
- eliglustat
- encorafenib
- enfortumab vedotin
- enoxaparin
- entrectinib
- enzalutamide
- epirubicin
- epoprostenol
- eptifibatide
- ergonovine
- ergotamine
- erlotinib
- escitalopram
- esterified estrogens
- estradiol
- estradiol topical
- estrone
- estropipate
- eszopiclone
- ethinyl estradiol
- ethosuximide
- etodolac
- etonogestrel
- etoposide
- etravirine
- everolimus
- exemestane
F
- fedratinib
- felodipine
- fenfluramine
- fenofibrate
- fenoprofen
- fentanyl
- finerenone
- flibanserin
- fludrocortisone
- fluoxetine
- flurazepam
- flurbiprofen
- fluticasone
- fluvoxamine
- fondaparinux
- fosamprenavir
- fosaprepitant
G
H
I
- ibritumomab
- ibrutinib
- ibuprofen
- idelalisib
- iloprost
- imatinib
- indinavir
- indomethacin
- infigratinib
- inotersen
- interferon beta-1a
- interferon beta-1b
- iodine i 131 tositumomab
- irinotecan
- irinotecan liposomal
- isavuconazonium
- isoniazid
- isradipine
- ivabradine
- ivacaftor
- ivosidenib
- ixabepilone
- ixazomib
K
L
- lapatinib
- larotrectinib
- leflunomide
- lemborexant
- lenacapavir
- leniolisib
- lepirudin
- letermovir
- levamlodipine
- levobupivacaine
- levoketoconazole
- levomethadyl acetate
- levomilnacipran
- levonorgestrel
- lidocaine
- linagliptin
- lomitapide
- lonafarnib
- lumateperone
- lurasidone
M
- macitentan
- maraviroc
- maribavir
- meclofenamate
- medroxyprogesterone
- mefenamic acid
- mefloquine
- megestrol
- meloxicam
- methadone
- methotrexate
- methoxsalen
- methyl aminolevulinate topical
- methylergonovine
- methysergide maleate
- midazolam
- midostaurin
- mifepristone
- milnacipran
- mipomersen
- mirabegron
- mirtazapine
- mitapivat
- mobocertinib
- modafinil
- montelukast
N
- nabumetone
- naloxegol
- naltrexone
- naproxen
- nelfinavir
- nicardipine
- nifedipine
- nilotinib
- nimodipine
- nirogacestat
- nisoldipine
- nitisinone
- norethindrone
- norgestrel
O
- olaparib
- oliceridine
- olutasidenib
- omacetaxine
- omaveloxolone
- osilodrostat
- osimertinib
- oxaprozin
- oxycodone
P
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- palbociclib
- palovarotene
- panobinostat
- paroxetine
- pazopanib
- pegaspargase
- peginterferon beta-1a
- pemigatinib
- pentosan polysulfate sodium
- pentoxifylline
- perampanel
- pexidartinib
- phenobarbital
- phenylbutazone
- piroxicam
- pirtobrutinib
- plicamycin
- ponatinib
- porfimer
- pralsetinib
- prasugrel
- praziquantel
- progesterone
- progesterone topical
Q
R
- ramelteon
- ramucirumab
- ranolazine
- regorafenib
- relugolix
- remdesivir
- repaglinide
- repotrectinib
- resmetirom
- reteplase
- ribociclib
- rifampin
- rifapentine
- rilpivirine
- ripretinib
- ritlecitinib
- ritonavir
- rivaroxaban
- rolapitant
- ruxolitinib
S
- saquinavir
- saxagliptin
- selpercatinib
- selumetinib
- sertraline
- sibutramine
- sildenafil
- silodosin
- sirolimus
- sirolimus protein-bound
- solifenacin
- sonidegib
- sorafenib
- sotorasib
- sparsentan
- streptokinase
- sulfinpyrazone
- sulindac
- sunitinib
- suvorexant
T
- tacrolimus
- tadalafil
- tamoxifen
- tasimelteon
- tazemetostat
- tecovirimat
- telaprevir
- telithromycin
- temsirolimus
- tenecteplase
- teriflunomide
- thioguanine
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tolmetin
- tolvaptan
- toremifene
- tositumomab
- trabectedin
- tramadol
- treprostinil
- trimethoprim
- tucatinib
U
V
- valoctocogene roxaparvovec
- vemurafenib
- venetoclax
- venlafaxine
- verteporfin
- vilazodone
- vonoprazan
- vorapaxar
- vortioxetine
W
Z
More about Ojemda (tovorafenib)
- Ojemda consumer information
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- FDA approval history
- Drug class: multikinase inhibitors
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.